Human Factors Risk Management as a Way to Improve Medical Device Safety: A Case Study of the Therac 25 Radiation Therapy System

Edmond W. Israelski Ph.D., C.H.F.P. (Program Manager), William H. Muto Ph.D., C.P.E. (Principal Human Factors Engineer)
{"title":"Human Factors Risk Management as a Way to Improve Medical Device Safety: A Case Study of the Therac 25 Radiation Therapy System","authors":"Edmond W. Israelski Ph.D., C.H.F.P. (Program Manager),&nbsp;William H. Muto Ph.D., C.P.E. (Principal Human Factors Engineer)","doi":"10.1016/S1549-3741(04)30082-1","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>In a fatal incident in 1984 much discussed in the literature, a patient received 16,000 rads instead of the intended 180 rads when undergoing radiation treatment. This incident likely could have been prevented by the use of risk analysis.</p></div><div><h3>Risk Analysis</h3><p>Risk analysis techniques to identify use errors have received increasing attention in health care. Use errors are defined as a pattern of predictable human errors that can be attributable to inadequate or improper design. Among the most widely used of the risk analysis tools are Failure Modes and Effects Analysis (FMEA) and fault tree analysis (FTA). The Therac 25 Radiation Therapy System incidents involved a combination of technical failures (software and possibly hardware) combined with human behavior resulting in catastrophic radiation overdoses.</p></div><div><h3>Summary and Conclusions</h3><p>From a manufacturer’s perspective, FMEAs and FTAs are valuable methods to systematically evaluate a medical device design’s potential for inducing use errors. When these risk analyses are done early in the development cycle, potential faults and their resulting hazards are identifiable and much easier to mitigate with error-reducing designs. These risk management methods are excellent complements to other important user-centered design best practices.</p></div>","PeriodicalId":84970,"journal":{"name":"Joint Commission journal on quality and safety","volume":"30 12","pages":"Pages 689-695"},"PeriodicalIF":0.0000,"publicationDate":"2004-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1549-3741(04)30082-1","citationCount":"49","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Joint Commission journal on quality and safety","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1549374104300821","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 49

Abstract

Background

In a fatal incident in 1984 much discussed in the literature, a patient received 16,000 rads instead of the intended 180 rads when undergoing radiation treatment. This incident likely could have been prevented by the use of risk analysis.

Risk Analysis

Risk analysis techniques to identify use errors have received increasing attention in health care. Use errors are defined as a pattern of predictable human errors that can be attributable to inadequate or improper design. Among the most widely used of the risk analysis tools are Failure Modes and Effects Analysis (FMEA) and fault tree analysis (FTA). The Therac 25 Radiation Therapy System incidents involved a combination of technical failures (software and possibly hardware) combined with human behavior resulting in catastrophic radiation overdoses.

Summary and Conclusions

From a manufacturer’s perspective, FMEAs and FTAs are valuable methods to systematically evaluate a medical device design’s potential for inducing use errors. When these risk analyses are done early in the development cycle, potential faults and their resulting hazards are identifiable and much easier to mitigate with error-reducing designs. These risk management methods are excellent complements to other important user-centered design best practices.

人为因素风险管理作为提高医疗器械安全性的途径:以therac25放射治疗系统为例
在1984年发生的一起致命事件中,一名患者在接受放射治疗时接受了16000拉德的辐射,而不是预期的180拉德。这一事件很可能是可以通过使用风险分析来预防的。风险分析识别使用错误的风险分析技术在卫生保健领域受到越来越多的关注。使用错误被定义为一种可预测的人为错误模式,可归因于不充分或不适当的设计。其中最广泛使用的风险分析工具是失效模式和影响分析(FMEA)和故障树分析(FTA)。Therac 25放射治疗系统事件涉及技术故障(软件和可能的硬件)与人类行为相结合,导致灾难性的辐射过量。从制造商的角度来看,fmea和fta是系统评估医疗器械设计诱导使用错误潜力的有价值的方法。当在开发周期的早期完成这些风险分析时,潜在的错误及其产生的危害是可识别的,并且更容易通过减少错误的设计来减轻。这些风险管理方法是对其他重要的以用户为中心的设计最佳实践的极好补充。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信